The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
Open accessAbstract
Hybrid polar compounds, of which hexamethylenebisacetamide (HMBA) is the prototype, are potent inducers of differentiation of murine erythroleukemia (MEL) cells and a wide variety of other transformed cells. HMBA has been shown to induce differentiation of neoplastic cells in patients, but is not an adequate therapeutic agent because of dose-limiting toxicity. We report on a group of three potent second generation hybrid polar compounds, diethyl bis-(pentamethylene-N,N-dimethylcarboxamide) malonate (EMBA), suberoylanilide hydroxamic acid (SAHA), and m-carboxycinnamic acid bis-hydroxamide (CBHA) with optimal concentrations for inducing MEL cells of 0.4 mM, 2 microM, and 4 microM, respectively, compared to 5 mM for HMBA. All three agents induce accumulation of underphosphorylated pRB; increased levels of p2l protein, a prolongation of the initial G1 phase of the cell cycle; and accumulation of hemoglobin. However, based upon their effective concentrations, the cross-resistance or sensitivity of an HMBA-resistant MEL cell variant, and differences in c-myb expression during induction, these differentiation-inducing hybrid polar compounds can be grouped into two subsets, HMBA/EMBA and SAHA/CBHA. This classification may prove of value in selecting and planning prospective preclinical and clinical studies toward the treatment of cancer by differentiation therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Burnette, W. N. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90281-5 · Cited by 8,429
Friend, C., Scher, W., Holland, J. G., & Sato, T. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.2.378 · Cited by 1,352
Cell Biology: a Laboratory Handbook
Harris, A. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.9.759 · Cited by 1,225
Cell biology :a laboratory handbook.
Celis, J. E. (1994) · Cited by 1,209
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119
A new group of potent inducers of differentiation in murine erythroleukemia cells.
Reuben, R. C., Wife, R. L., Breslow, R., Rifkind, R. A., & Marks, P. A. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.3.862 · Cited by 370
Self-citationConstitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation.
Clarke, M. F., Kukowska-Latallo, J. F., Westin, E., Smith, M., & Prochownik, E. V. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.884 · Cited by 298
Fibach, E., Reuben, R. C., Rifkind, R. A., & Marks, P. A. (1977) · PubMed · Cited by 190
Self-citationAndreeff, M., Stone, R. M., Michaeli, J., Cw, Y., Tong, W., Sogoloff, H., Ervin, T. J., Kufe, D. W., Rifkind, R. A., & Marks, P. (1992) · Blood · doi:10.1182/blood.v80.10.2604.2604 · Cited by 124
Self-citationMarks, P. A., Richon, V. M., Kiyokawa, H., & Rifkind, R. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10251 · Cited by 89
Self-citationStowell, J. C., Huot, R. I., & Voast, L. V. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00008a020 · Cited by 64
Potent cytodifferentiating agents related to hexamethylenebisacetamide.
Breslow, R., Jursic, B., Yan, Z. F., Friedman, E., Leng, L., Ngo, L., Rifkind, R. A., & Marks, P. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5542 · Cited by 63
Self-citationRichon, V. M., Rifkind, R. A., & Marks, P. A. (1992) · PubMed · Cited by 54
Self-citationMcMahon, J., Km, H., & Rj, W. (1988) · PubMed · Cited by 43
Marks, P. A. (1996) · International Journal of Hematology · doi:10.1016/0925-5710(95)00428-9 · Cited by 35
Self-citationZhuo, S., Fan, S., Huang, S., & Kaufman, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4234 · Cited by 20
Cited by
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
“Hydroxamates, such as SAHA and pyroxamide, are members of a class of HDAC inhibitors that are amenable to extensive structure–activity studies, and optimization of the SAHA structure has yielded compounds with subnanomolar activitie”
BackgroundSelf-citationHow were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Self-citationMarks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,196
Self-citationRichon, V. M., Sandhoff, T. W., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316197 · Cited by 1,090
Self-citation
Metadata
- Authors
- Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A., & Marks, P. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-06-11
- Volume
- 93
- Issue
- 12
- Pages
- 5705-5708
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2032025865
- Cited by
- 420
- References
- 18
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.